INTRODUCTION
Pneumonia is the most common form of neonatal infection and one of the most important causes of perinatal death. 1 The diagnosis of pneumonia in the term or near-term neonate in the normal Newborn Nursery (NBN) is based on clinical and radiographic findings, with blood cultures rarely yielding an etiologic agent; failure to obtain an organism may be secondary to previous exposure to antibiotics, or because the infection is localized or caused by a viral agent. Although respiratory distress presenting at the time of birth has been well described with neonatal pneumonia, 1, 2 in our experience, neonates with pneumonia generally are asymptomatic for 8 to 24 hours after birth. Furthermore, while the initial chest radiograph may be consistent with either retained lung fluid or pneumonia, failure to clear or a worsening picture on subsequent films suggests the diagnosis of pneumonia. 3 A review of our database revealed that 141 infants were diagnosed with pneumonia in 1997; this group represented 1.1% of the 12,526 admissions to the NBN during that year. In general, neonates with the diagnosis of pneumonia in the NBN received broad spectrum intravenous antibiotics, usually ampicillin and gentamicin, for a total of 7 days. 4 Determining the duration of antibiotic therapy for neonatal pneumonia poses a dilemma for the clinician; the infection must be adequately treated, while avoiding needlessly prolonged hospitalization and exposure to antibiotics. In our experience, many
OBJECTIVE:
To compare a 4 -day course of antibiotic therapy to a 7 -day course in selected term and near -term neonates with pneumonia.
METHODS:
The diagnosis of pneumonia was made in neonates admitted to the normal Newborn Nursery ( NBN ) who later had signs of respiratory distress and whose chest radiographs were consistent with pneumonia. Infants were excluded if any of the following was present: moderate or thick meconiumstained amniotic fluid, prior antibiotic therapy > 24 hours, or need for supplemental oxygen > 8 hours. Infants who were asymptomatic after 48 hours of antibiotic therapy were prospectively randomized to a 4 -day group ( n = 35 ) or a 7 -day group ( n = 38 ) . Infants in the 4 -day group were observed in the hospital for 24 hours following cessation of antibiotics and were seen in follow up within several days of discharge.
RESULTS:
The groups were comparable with regard to demographic factors, duration of rupture of membranes, and incidence of maternal chorioamnionitis. Median postnatal age at the time of identification of respiratory distress symptomatology was 19 hours ( range 0.5 to 55 hours ) in the 4 -day group and 12 hours ( range 1 to 72 hours ) in the 7 -day group. No study infants had a positive blood culture. Mean reduction in length of hospitalization was 2.1 days, with estimated savings of greater than US$700 per shortened hospitalization. Two infants in the 4 -day group developed tachypnea during the 24 -hour observation period. However, no infants were rehospitalized for sepsis or pneumonia following discharge. With 95% confidence, the true rate of success for the 4 -day group was at least 92%.
CONCLUSION:
Four days of antibiotic therapy plus a 24 -hour period of observation for selected cases of neonatal pneumonia appears to be comparable to 7 days of therapy. It is important to note that newborns in our institution receive a single dose of penicillin soon after birth as part of our group B streptococcal sepsis prophylaxis program, and all infants in this study received prophylaxis prior to the onset of respiratory symptoms. Furthermore, only infants who were asymptomatic after 48 hours of antibiotic therapy were included in this study, and a 24 -hour observation period at the end of the 4 -day course was required. These qualifications should be taken into account before use of this approach is considered, and additional studies are necessary to further establish its safety and benefits. 
Original Article
infants with radiographically and clinically diagnosed pneumonia responded promptly to therapy, and continuing to administer antibiotic therapy for 7 days seemed excessive. Therefore, we hypothesized that for selected neonates diagnosed with pneumonia, 4 days of antibiotic therapy would be comparable to 7 days. A combined obstetrical±neonatal approach to prevent group B streptococcal infection was implemented at our institution in January 1995, and was in effect during this study. 5 Women with preterm labor ( <37 completed weeks by last menstrual period, or clinical and ultrasound examination), prolonged rupture of membranes (18 hours), or a previous infant with group B streptococcal infection received intravenous ampicillin (2 gm every 6 hours). All infants received aqueous penicillin G 50,000 U intramuscularly within 1 hour of delivery. Exceptions were those infants whose mothers had chorioamnionitis treated with ampicillin and gentamicin during labor; asymptomatic neonates with negative blood cultures in the latter group received ampicillin and gentamicin intramuscularly for 48 hours following delivery.
METHODS

Infants
Prior to initiation of antibiotic therapy for pneumonia, a single blood culture and complete blood count with differential cell count were obtained. Neutrophil values were analyzed according to the reference ranges for absolute total neutrophils (ATN), absolute total immature neutrophils (ATI), and the proportion of immature:total neutrophils (I:T) as reported by Manroe et al. 6 The radiographic diagnosis of pneumonia in study patients was based on the finding of persistent perihilar streakiness and/or peripheral fluffy infiltrates. 3 Sequential radiographs were obtained in most cases to reduce the likelihood of misdiagnosing retained lung fluid, and radiographic findings were confirmed by Pediatric Radiology staff, as well as by at least two attending physicians in the NBN. Infants received intravenous ampicillin 50 mg/kg every 8 hours and gentamicin 2.5 mg/kg every 12 hours.
Only neonates with the diagnosis of pneumonia who were asymptomatic (respiratory rate <70 breaths/minute, absence of grunting, flaring and retractions, no need for supplemental oxygen, and feeding orally) after 48 hours of antibiotic therapy were eligible for randomization by selection of a sealed, opaque envelope to either the 4-day (2 additional days of antibiotic therapy) or the 7-day (5 additional days of antibiotic therapy) group. Infants were excluded from the study prior to randomization if: (a) there was moderate or thick meconium staining of the amniotic fluid; (b) they had received postnatal antibiotics for another reason, such as maternal chorioamnionitis (diagnosed by maternal temperature 388C during labor), for >24 hours at the time of diagnosis of pneumonia; (c) respiratory symptoms (respiratory rate 70 breaths/minute, grunting, flaring, and/or retractions) persisted >48 hours after initiation of antibiotics for pneumonia; (d) the chest radiograph was not consistent with pneumonia; (e) sustained oxygen supplementation for greater than 8 hours (in which case infants were transferred to the NICU and not included in the study); or (f) failure to obtain parental consent. One infant was excluded prior to randomization when the diagnosis of congenital viral syndrome with pneumonia became apparent.
In both study groups, parents were contacted by phone within 1 to 2 days following their infant's discharge from the hospital. In addition, since infants in the 4-day group received less therapy, they were: (a) observed in the nursery for 24 hours following discontinuation of antibiotics and prior to discharge and (b) reexamined as an outpatient within 2 to 3 days following discharge. Therapy was considered to be successful if the infant fed well with no apparent respiratory distress following discharge, as ascertained by phone contact and/or direct observation, and if there was no subsequent need for rehospitalization for sepsis and/or pneumonia. This study was approved by the Institutional Review Boards at The University of Texas Southwestern Medical Center at Dallas and Parkland Memorial Hospital, and informed parental consent was obtained for all infants.
Sample Size To our knowledge, there has been no formal attempt to estimate the probability of a successful outcome with the 7-day treatment. Our experience with this length of therapy has been favorable, and we would estimate that the probability of a successful outcome is at least 0.98. Whatever its value, establishing equivalence of the two treatments (4-day and 7-day) would require a sample size ranging anywhere from 850 to 8400, depending on relatively minor variations in the assumptions that were made. 7 We elected to proceed with a sample size sufficient to assess the feasibility of the new therapy and, for each treatment, to yield a reasonably high 95% lower confidence bound on the probability of a successful outcome (defined as infants doing well, as ascertained by phone contact or direct observation, and Engle et al.
Neonatal Pneumonia no rehospitalization for sepsis or pneumonia). It was considered likely that for a moderate number of subjects, there would be few, if any, unfavorable outcomes for either treatment. For planning purposes, we plotted the 95% lower confidence bound versus sample size, assuming no unfavorable outcomes. As sample size increases, the curve quickly rises and then``flattens out'' ( Figure 1 ). We concluded that at least 35 in each treatment group would be adequate both to appraise the viability of the new treatment and to establish 95% confidence bounds for both therapies that exceeded the 90% level. 8 
Statistical Analysis
An intention-to-treat analysis was performed. Continuous data were evaluated using Student's t-test or the Wilcoxon rank sum test; categorical variables were analyzed using Fisher's exact test or chi square contingency table analysis. 8, 9 A significance level of 0.05 was used.
RESULTS
Two hundred twelve infants with presumed pneumonia based on clinical and radiographic findings received antibiotic therapy during the study period; this group represents 1.7% of the infants admitted to the NBN during this period. One hundred thirty-nine infants who received antibiotics for pneumonia were excluded from the study prior to randomization (Table 1 ). This group included 51 neonates with clinical pneumonia in whom chest X-rays were not diagnostic of pneumonia; demographic variables in these neonates were comparable to those in the two study groups. These infants responded well to 5 to 7 days of antibiotic therapy. Seventy-three neonates met the criteria for randomization: 35 were randomized to the 4-day group and 38 to the 7-day group.
Characteristics of the neonates in the 4-day and 7-day groups are shown in Table 2 . Birth weight, gestational age, ethnicity, route of delivery, Apgar scores, cord pH, age of onset of respiratory symptoms, and age at initiation of antibiotic therapy were similar between the groups. Twenty-one neonates in each group (67% and 59% of the neonates in the 4-and 7-day groups, respectively) were greater than 8 hours of age when they developed respiratory distress. The Figure 1 . Illustration of the 95% lower confidence bound assuming successful outcomes. The dotted line illustrates that for the number of subjects in the 4-day group (35 ) , the 95% lower confidence bound is approximately 92%. male:female proportion was higher in the 4-day group (p=0.05), and duration of respiratory distress was longer in the 7-day group (p=0.05). One infant who was randomized to the 7-day group received only 4 days of treatment because the mother of the baby signed out against medical advice. Because of the intention-to-treat design of the study, this infant's data were analyzed as part of the 7-day group. Sepsis risk factors and prior exposure of study infants to antibiotics are shown in Table 3 . The mothers of four babies in each group had rupture of membranes 18 hours. The number of babies whose mothers received intrapartum antibiotics for chorioamnionitis or preterm labor <37 weeks, and the number of infants who received postnatal antibiotics prior to the onset of respiratory distress for chorioamnionitis exposure were similar between the groups. The remainder of the study infants received a single dose of aqueous penicillin G 50,000 U intramuscularly within 1 hour of delivery as part of our group B streptococcal prophylaxis protocol.
The majority of infants (60% and 58% in the 4-and 7-day groups, respectively) presented with tachypnea alone. An additional 20% and 29% of the 4-and 7-day infants, respectively, manifested tachypnea with grunting, retractions, and/or nasal flaring (p=0.50). Chest radiographic findings in study patients were as described above. More than one chest X-ray was obtained in 94% and 89% of the 4-and 7-day neonates, respectively. In a blinded, retrospective review of chest radiographs obtained in study patients and patients with other diagnoses, performed by one of the investigators (M. A. P.), the concordance with the original diagnosis was 83%. Only one CBC was obtained in 26% and 22% of the 4-and 7-day groups, respectively, and two or more CBCs were obtained in the remaining study infants. Neutrophil values were abnormal in 66% of infants in the 4-day group and 76% of those in the 7-day group (p=0.46; Table 4 ). None of the blood cultures obtained in any of the study infants was positive.
As anticipated by the study design, there was a 2-day difference in length of hospitalization between the 4-day (6.01.3 days, range 5 to 11) and the 7-day (8.11.4 days, range 4 to 14) groups (p<0.0001). This reduction in length of stay in our institution would result in greater than US$700 in decreased patient charges per hospitalization. High rates of phone contact in both groups (97% and 100% in the 4-and 7-day groups, respectively) and for return for follow-up in the 4-day group (100%) were observed. All infants were doing well as ascertained by phone contact or direct observation, and no study infants were rehospitalized for sepsis or pneumonia. Two infants in the 4-day group developed tachypnea during the 24-hour observation period, while being considered asymptomatic after 48 hours of antibiotic therapy and at the completion of the 4-day course of antibiotics. In one instance, the symptoms resolved and the infant was discharged 2 days later. In the second case, tachypnea persisted, work up for other causes of respiratory distress was negative, chest radiograph showed persistent infiltrates, and antibiotic therapy was restarted; this infant was treated for an additional 5 days and then discharged without further problems. Based on our study protocol, which included a 24-hour observation period, both of these infants were successfully treated. At the time enrollment into the study was discontinued, the point estimate of success for 4 days of therapy plus observation was 100%. Furthermore, with 95% confidence, the true rate of success was at least 92% for both the 4-and 7-day groups.
DISCUSSION
The optimal length of antibiotic therapy for neonatal pneumonia is unclear, which may be a reflection of the diverse clinical manifestations of this disorder. Recommendations vary from 7 days 4 to as long as 3 to 6 weeks 2 for disease caused by S. aureus. Treatment must be adequate to prevent relapse, while therapy should not be excessive, particularly in the age of early discharge. Therefore, it would be helpful to more clearly define subpopulations of infants with pneumonia who may benefit from a shorter course of antibiotic therapy. Experience in our NBN indicated that, while 7 days of therapy was adequate in the vast majority of neonates, it appeared that a selected group of patients, i.e., those whose respiratory signs resolved within 48 hours of the initiation of therapy, might respond to a shorter course. The decision to evaluate a 4-day course, and to y ATN = absolute total neutrophil count; ATI = absolute total immature neutrophil count; I:T = proportion of immature to total neutrophil count. ( Ref. 6 ). *Values in parentheses are percentages. compare this period to a 7-day course, was made because this length of therapy would allow 2 additional days of antibiotic therapy following symptom resolution but, if shown to be successful, would substantially reduce duration of hospitalization. The diagnosis of pneumonia in the term and near-term neonate is challenging and is based on clinical assessment of the baby in conjunction with supporting information, primarily the interpretation of sequential chest radiographs. 3 Although previous studies have shown considerable variability among radiologists' interpretations of chest radiographs 10 a retrospective review by one of us (M. A. P.), performed without benefit of corresponding clinical information, yielded a concordance of 83% with the original radiographic diagnosis. Other methods to establish the diagnosis and etiology of neonatal pneumonia have included gastric aspirates, tracheal aspirates, and in some instances, lung puncture. 11 ± 13 Others have noted the usefulness of acute phase reactants, such as C-reactive protein, or sequential neutrophil values in this clinical setting. 14, 15 Although the majority of the infants in this study had abnormal neutrophil values, this finding was not a requirement for entry into the study, and acute phase reactants were not measured systematically. Philip 4 has noted that respiratory distress developing after the first 12 hours postnatal is strongly indicative of the diagnosis of pneumonia. In the current study, the median postnatal age at which signs of respiratory distress appeared was 19 and 12 hours in the 4-and 7-day groups, respectively. Furthermore, the majority of infants in each of the treatment groups were well until at least 8 hours after birth. This delay in presentation makes it much less likely that infants with retained lung fluid or an aspiration syndrome were included in the study groups. 16, 17 It should be noted that 90 infants who did not have pneumonia but were diagnosed with retained lung fluid (based on sequential chest radiographic findings and clinical course) were ill enough to be admitted to the Observation Nursery during the study.
As shown in Table 1 , we excluded a significant number of babies who received treatment for presumed pneumonia during the study period. Although the 37 infants exposed to moderate or thick meconium-stained amniotic fluid were felt to have a course more consistent with pneumonia than with meconium aspiration, they were excluded since this distinction often is difficult. In 51 neonates, the clinical course strongly suggested pneumonia, although the chest radiographs were not considered diagnostic. The finding of pneumonia at autopsy with a normal chest radiograph prior to death has been reported. 3 Although we elected to include only infants in whom the chest radiographs were consistent with pneumonia in this randomized trial, it is plausible that our conclusions, with further study, could be generalized to those with chest radiographs not diagnostic of pneumonia as well as to neonates with meconiumstained amniotic fluid. In addition, while sequential chest X-rays appear to be helpful in establishing the presence of pneumonia, and the absence of retained lung fluid, it is possible that the diagnosis of pneumonia could be made with fewer radiographs, with a greater interval between exams, than in the current study.
There were marginal statistical differences in gender and duration of respiratory symptoms between the 4-and 7-day groups. Since these differences occurred as part of the randomization process and were not related to duration of therapy, we do not feel that they are clinically significant. The longer interval between median values for age at onset of respiratory symptoms and age at initiation of antibiotics (11 vs 1 hour in the 7-and 4-day groups, respectively) suggests that the apparent need for immediate antibiotic therapy was more common in the 4-day group; however, analysis of respiratory symptomatology suggests that the groups are comparable.
True hospital costs are difficult to define; using hospital charges as an estimate, we project that a reduction in length of stay of 2 to 3 days for an infant in our observation nursery would result in savings of greater than US$700. In our institution, with 100 to 200 term and near-term infants diagnosed with pneumonia per year, these savings would be substantial. Other potential benefits which might result from a shorter course of antibiotic therapy, such as enhanced parent±infant bonding, improved lactation, and reduced antibiotic resistance were not examined in this study.
In selected term and near-term neonates with pneumonia, 4 days of antibiotic therapy appears to be a feasible alternative to 7 days of therapy. It should be emphasized that this conclusion applies only to those infants who were free of symptoms after 48 hours of antibiotic therapy with no need for supplemental oxygen and in whom no bacterial pathogen was isolated. These infants should be distinguished from those begun on antibiotics for``rule out sepsis'' scenarios who, after 48 hours, are clinically well, diagnostic tests have failed to yield a diagnosis, and antibiotics are discontinued. Based on their presentation and radiographic findings, we considered that the infants enrolled in the current study were infected. It also should be emphasized that all of the study infants received either a single dose of intramuscular penicillin within 1 hour of delivery or, in the case of four infants, were begun on intramuscular ampicillin and gentamicin soon after delivery because of exposure to maternal chorioamnionitis treated with antibiotics during labor. Our practice of early universal antibiotic administration may have influenced both the time of onset of respiratory symptoms as well as the duration of antibiotic therapy.
Based on our finding of two infants who developed tachypnea during the 24-hour observation period, we suggest that a similar interval of closely monitored follow up is advisable if this program were to be implemented. This suggestion is analogous to the American Academy of Pediatrics recommendation that all neonates who participate in an early discharge program should be seen in follow up within 2 to 3 days of discharge from the hospital. Our decision to consider these two infants in the``successfully treated'' category was based not just on 4 days of antibiotic therapy but on 4 days of therapy in conjunction with a period of observation. It appears that this approach would allow many neonates to benefit from a shorter course of antibiotic therapy, while capturing the few infants who might require additional hospitalization and/or treatment. Additional randomized trials are required to further establish the safety and benefits of an abbreviated course of antibiotics for neonatal pneumonia.
